chr4-77158583-T-C
Position:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2
The NM_004354.3(CCNG2):āc.51T>Cā(p.Leu17Leu) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000829 in 1,614,136 control chromosomes in the GnomAD database, including 11 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ā ).
Frequency
Genomes: š 0.0047 ( 5 hom., cov: 33)
Exomes š: 0.00043 ( 6 hom. )
Consequence
CCNG2
NM_004354.3 synonymous
NM_004354.3 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.238
Genes affected
CCNG2 (HGNC:1593): (cyclin G2) The eukaryotic cell cycle is governed by cyclin-dependent protein kinases (CDKs) whose activities are regulated by cyclins and CDK inhibitors. The 8 species of cyclins reported in mammals, cyclins A through H, share a conserved amino acid sequence of about 90 residues called the cyclin box. The amino acid sequence of cyclin G is well conserved among mammals. The nucleotide sequence of cyclin G1 and cyclin G2 are 53% identical. Unlike cyclin G1, cyclin G2 contains a C-terminal PEST protein destabilization motif, suggesting that cyclin G2 expression is tightly regulated through the cell cycle. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.73).
BP6
Variant 4-77158583-T-C is Benign according to our data. Variant chr4-77158583-T-C is described in ClinVar as [Benign]. Clinvar id is 787030.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.238 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.00466 (710/152258) while in subpopulation AFR AF= 0.0166 (688/41548). AF 95% confidence interval is 0.0155. There are 5 homozygotes in gnomad4. There are 320 alleles in male gnomad4 subpopulation. Median coverage is 33. This position pass quality control queck.
BS2
High AC in GnomAd4 at 710 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CCNG2 | NM_004354.3 | c.51T>C | p.Leu17Leu | synonymous_variant | 2/8 | ENST00000316355.10 | NP_004345.1 | |
CCNG2 | XM_011532398.2 | c.51T>C | p.Leu17Leu | synonymous_variant | 2/8 | XP_011530700.1 | ||
CCNG2 | XM_011532399.3 | c.51T>C | p.Leu17Leu | synonymous_variant | 2/8 | XP_011530701.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CCNG2 | ENST00000316355.10 | c.51T>C | p.Leu17Leu | synonymous_variant | 2/8 | 1 | NM_004354.3 | ENSP00000315743.5 |
Frequencies
GnomAD3 genomes AF: 0.00466 AC: 709AN: 152140Hom.: 5 Cov.: 33
GnomAD3 genomes
AF:
AC:
709
AN:
152140
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00116 AC: 292AN: 251494Hom.: 2 AF XY: 0.000912 AC XY: 124AN XY: 135920
GnomAD3 exomes
AF:
AC:
292
AN:
251494
Hom.:
AF XY:
AC XY:
124
AN XY:
135920
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000430 AC: 628AN: 1461878Hom.: 6 Cov.: 31 AF XY: 0.000366 AC XY: 266AN XY: 727244
GnomAD4 exome
AF:
AC:
628
AN:
1461878
Hom.:
Cov.:
31
AF XY:
AC XY:
266
AN XY:
727244
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00466 AC: 710AN: 152258Hom.: 5 Cov.: 33 AF XY: 0.00430 AC XY: 320AN XY: 74446
GnomAD4 genome
AF:
AC:
710
AN:
152258
Hom.:
Cov.:
33
AF XY:
AC XY:
320
AN XY:
74446
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Aug 16, 2018 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at